Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use-Reference-Cited by-同舟云学术

Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use

Published:2021-10-20 Issue:1 Volume:47 Page:97-103
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Shin Juyoung¹²,Kim Hyunah³,Yim Hyeon Woo⁴,Kim Ju Han⁵,Lee Suehyun⁶⁷,Kim Hun‐Sung²⁸^ORCID

Affiliation:

1. Health Promotion Center Seoul St. Mary’s Hospital Seoul Korea

2. Division of Endocrinology and Metabolism Department of Internal Medicine Seoul St. Mary’s HospitalCollege of MedicineThe Catholic University of Korea Seoul Korea

3. College of Pharmacy Sookmyung Women’s University Seoul Korea

4. Department of Preventive Medicine College of Medicine The Catholic University of Korea Seoul Korea

5. Division of Biomedical Informatics Systems Biomedical Informatics Research Center Seoul National University College of Medicine Seoul Korea

6. Department of Biomedical Informatics College of Medicine Konyang University Daejeon Korea

7. Health Care Data Science Center Konyang University Hospital Daejeon Korea

8. Department of Medical Informatics College of Medicine The Catholic University of Korea Seoul Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13544

Reference31 articles.

1. Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status

2. Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data

3. Drug-induced diabetes mellitus

4. Drug-Induced Hyperglycaemia and Diabetes

5. Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism